4EGI-1

4EGI-1 Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: Product Name:4EGI-1
CAS:315706-13-9
Purity:98% HPLC Package:5MG;10MG;50MG;100MG,1G,5G
Company Name: BOC Sciences
Tel: +1-631-485-4226
Email: inquiry@bocsci.com
Products Intro: Product Name:4EGI-1
CAS:315706-13-9
Purity:>98% Package:25mg Remarks:BOC Sciences also provides custom synthesis services for 4EGI-1.
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:4EGI-1;4EGI1;4EGI 1
CAS:315706-13-9
Purity:96.80% Package:1 mL * 10mM (in DMSO);10 mg;100 mg;2 mg;25 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Career Henan Chemica Co
Tel: +86-0371-86658258 +8613203830695
Email: laboratory@coreychem.com
Products Intro: Product Name:4EGI-1
CAS:315706-13-9
Purity:95% Package:1g;17.0USD
Company Name: Zhejiang J&C Biological Technology Co.,Limited
Tel: +1-2135480471 +1-2135480471
Email: sales@sarms4muscle.com
Products Intro: Product Name:4EGI-1
CAS:315706-13-9
Purity:99% Package:5KG;1KG Remarks:4EGI-1
4EGI-1 Basic information
Product Name:4EGI-1
Synonyms:4EGI-1;α-[2-[4-(3,4-Dichlorophenyl)-2-thiazolyl]hydrazinylidene]-2-nitro-benzenepropanoic acid;eIF4E/eIF4G Interaction Inhibitor, 4EGI-1;4EGI-1, >=98%;alpha-[2-[4-(3,4-Dichlorophenyl)-2-thiazolyl]hydrazinylidene]-2-nitrobenzenepropanoic acid;2-((4-(3,4-Dichlorophenyl)thiazol-2(3H)-ylidene)hydrazono)-3-(2-nitrophenyl)propanoic acid;CS-1408;CS-1896
CAS:315706-13-9
MF:C18H12Cl2N4O4S
MW:451.28
EINECS:2017-001-1
Product Categories:Inhibitors
Mol File:315706-13-9.mol
4EGI-1 Structure
4EGI-1 Chemical Properties
Boiling point 668.9±65.0 °C(Predicted)
density 1.58±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility ≥22.56 mg/mL in DMSO
form Brown solid.
pka0.89±0.41(Predicted)
color Light yellow to khaki
Safety Information
MSDS Information
4EGI-1 Usage And Synthesis
DescriptionIn eukaryotes, a set of initiation factors (eIFs) interact with ribosomal subunits to initiate mRNA translation. A major step in initiation is the assembly of a large multiprotein complex that includes the cap-binding protein eIF4E and the multidomain adaptor protein eIF4G. 4EGI-1 is an inhibitor of the initiation of translation that blocks the interaction of eIF4G with eIF4E (KD = 25 μM). It directly binds eIF4E, competitively inhibiting an association with eIF4G that is necessary for cap-dependent translation. 4EGI-1 prevents the expression of oncogenic proteins in mammalian cancer cells, leading to apoptosis. Research with this inhibitor supports a role for normal eIF4E/eIF4G interaction in memory consolidation and excess interaction in autism spectrum disorders. 4EGI-1 also blocks translation in some viruses that do not require eIF4E or a cap structure for initiation.
UseseIF4E/eIF4G Interaction Inhibitor, 4EGI-1 is amplifies TRAIL-induced apoptosis via down-regulation of FLIPS/L?and induction of DR5.
DefinitionChEBI: 4EGI-1 is a dichlorobenzene, a member of 1,3-thiazoles, a C-nitro compound, a monocarboxylic acid and a hydrazone.
storageStore at -20°C
references[1] moerke n j, aktas h, chen h, et al. small-molecule inhibition of the interaction between the translation initiation factors eif4e and eif4g. cell, 2007, 128(2): 257-267.
4EGI-1 Preparation Products And Raw materials
Tag:4EGI-1(315706-13-9) Related Product Information
Everolimus Cisplatin MK-2206 2HCl 4E1RCat PD 0332991 HCl PLX4032